Beginning in mid-February 2008, the 1997-2007 online version of the Science Watch® newsletter, ESI-Topics.com, and in-cites.com, will all be featured together on the redesigned ScienceWatch.com. All previous content from the three sites will be permanently archived, and remain accessible from any existing bookmarks to the archived pages. No new content will be added to this site. Updates and new content (updated biweekly) are available at ScienceWatch.com now.
The Thomson Corporation inin-cites logoites
ScientistsPapersInstitutionsJournalsCountriesH O M ERSS feeds


S E A R C H
incites



PAPERS

Scientists
Papers
Institutions
Journals
Countries
 

The Top 10...
Analysis of...
Site Map by Fields
Overview Menu of all Interviews
Podcasts
Hot Papers published within the last 2 years
Current Classics
SCI-BYTES - What's New in Research
What's New in Research

in-cites, October 2006
 http://www.in-cites.com/papers/ManuelCPeitsch.html

Papers

             
An interview with:
Prof. Manuel C. Peitsch
           

Acording to Essential Science Indicators, the paper "SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling" (Guex N, Peitsch MC, Electrophoresis 18[15]: 2714-23, December 1997) ranks at #2 among Chemistry papers published in the past decade, with 2,684 citations to date. In the interview below, in-cites talks with Professor Manuel Peitsch about this paper and its impact on the field. Professor Peitsch is the Global Head of Systems Biology, Genome and Protein Sciences at the Novartis Institute of Biomedical Research in Basel, Switzerland.

  Would you give us some background on your education and early research?

I am a biologist and physical chemist by training and obtained my Ph.D. in Biochemistry from the University of Lausanne (Switzerland) studying the antibody-independent activation of the classical complement pathway. During that time I got increasingly interested in protein structure as well as scientific computing. This led me to spend my post-doctoral years in the Laboratory of Mathematical Biology of the National Cancer Institute (Frederick, MD, USA) with J.V. Maizel, where I started to write methods and software tools to predict the 3D-structure of proteins using homology-based approaches. After my return to Switzerland, I used these tools to build an internet-based protein modeling server, which became SWISS-MODEL in 1993, when I wrote its interface using Web-based technology.

  Would you please sum up your 1997 Electrophoresis paper on SWISS-MODEL and Swiss-PdbViewer?

Prof. Manuel C. Peitsch
“One major driver behind our vision was to hide much of the complexity associated with protein modeling behind a simple and easy-to-use interface, thereby providing a very large community of scientists with the possibility to gain insights into the 3D structure of the proteins they are studying, without the need to learn and purchase complex and expensive software.”

When Nicolas Guex joined my group in 1995, we developed a vision of a completely integrated environment for protein structures prediction over the Web. Therefore we developed the Swiss-PdbViewer, which not only operates as a stand-alone application for protein structure analysis and modeling, but also acts as a client application to the SWISS-MODEL and ExPASy web servers.

The paper describes the software components and provides an example of their application. Furthermore, the paper describes the notion of large-scale protein modeling and the associated protein model repository, which later paved the way for the 3DCrunch experiment run in collaboration with Silicon Graphics. At the end of this experiment, the SWISS-MODEL Repository held over 64,000 model structures (Peitsch MC, Schwede T, Guex N, "Automated protein modeling—the proteome in 3D," Pharmacogenomics 1[3]:257-266, 2000).

  What is it about this paper that caused it to become so highly cited?

One major driver behind our vision was to hide much of the complexity associated with protein modeling behind a simple and easy-to-use interface, thereby providing a very large community of scientists with the possibility to gain insights into the 3D structure of the proteins they are studying, without the need to learn and purchase complex and expensive software.

There are probably four major factors contributing to the citation record. First, the server is easy to use, as the Web-interface takes away most of the complexity normally associated with protein modeling. Second, the Swiss-PdbViewer, which is available for most relevant computer platforms (MS, MAC, LINUX, and SGI), has many powerful and easy-to-use features developed by modelers for modelers. Third, the uninterrupted operations for 13 years allows over 50,000 users to build over 180,000 models and access nearly 1 million models available in the SWISS-MODEL Repository every year. And finally, Swiss-PdbViewer has an active user community kindly and efficiently coordinated by Gale Rhodes of the University of Southern Maine.

  Where is this work today—have SWISS-MODEL and Swiss-PdbViewer been upgraded in any significant way?

While the members of the original team moved on to new positions, the collaboration is still ongoing, and all three components of the environment are regularly upgraded and improved from an algorithmic, technical, and user interface perspective. I would, however, like to point out two significant developments by the group of Torsten Schwede at the University of Basel: first, a Web-based personal workspace which assists and guides the user in building protein homology models at different levels of complexity; and second, a completely reworked SWISS-MODEL Repository which now contains nearly 1 million model structures accompanied by detailed information about the target protein, the model building process, and model quality assessment.

  Who, besides your scientific collaborators, was instrumental for the success of SWISS-MODEL and Swiss-PdbViewer?

As a team we are particularly thankful to Timothy N.C. Wells (GlaxoWellcome, now at Merck-Serono), Jonathan C.K. Knowles (GlaxoWellcome, now at Roche), and Allan Baxter (GlaxoSmithKline) who have established the necessary environment for this project. Furthermore we are deeply indebted to Stanley K. Burt, Robert W. Lebherz, and Jack R. Collins as well as the whole staff at the Advanced Biomedical Computing Center at NCI-Frederick (Frederick, MD, USA) for their continuing support and operating the US mirror of the SWISS-MODEL server.

  If you are free to talk about it, what are your current projects?

In my current activities, I mainly focus on systems biology and the integration of experimental and mathematical approaches to the study of signaling networks. These include proteomics, computational systems biology, and text mining. I do, however, still collaborate with Torsten Schwede on SWISS-MODEL, Swiss-PdbViewer, and projects to employ GRID-based computing to accelerate high-throughput docking of small molecules into the binding pockets of protein structures.End of interview

Prof. Manuel C. Peitsch, Ph.D.
Global Head of Systems Biology
Genome and Proteome Sciences
Novartis Institute of BioMedical Research 
Novartis Pharma AG
Basel, Switzerland


Prof. Manuel C. Peitsch's most-cited paper with 701 cites to date:
Guex N, Peitsch MC, "SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling," Electrophoresis 18(15): 2714-23, December 1997. 2,684 cites.

Source: Essential Science Indicators


in-cites, October 2006
 http://www.in-cites.com/papers/ManuelCPeitsch.html


ScienceWatch.com - Tracking Trends and Perfomance in Basic Research
Go to the new ScienceWatch.com

Home | Search | Disclaimer | Terms of Use | Privacy Policy | Copyright
Contact Webmaster with questions/comments |
(c) 2008 The Thomson Corporation.